Shenzhen Chipscreen Biosciences Co (688321) — Financial Flexibility Index
Shenzhen Chipscreen Biosciences Co (688321) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥63.98 Million (operating CF CN¥2.25 Million minus capex CN¥61.73 Million) represents 0% of total liabilities (CN¥1.98 Billion). Also explore 688321 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shenzhen Chipscreen Biosciences Co Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Shenzhen Chipscreen Biosciences Co across 9 annual periods. Check 688321 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shenzhen Chipscreen Biosciences Co (2016–2024)
Year-by-year free cash flow to debt coverage for Shenzhen Chipscreen Biosciences Co. For the full company profile including market capitalisation, see market value of Shenzhen Chipscreen Biosciences Co.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | CN¥344.62 Million | CN¥76.13 Million | CN¥1.67 Billion | ▲ +259.1% |
| 2023 | 0.06x | CN¥85.82 Million | CN¥-143.21 Million | CN¥1.49 Billion | ▼ -82.9% |
| 2022 | 0.34x | CN¥443.46 Million | CN¥43.30 Million | CN¥1.32 Billion | ▼ -61.2% |
| 2021 | 0.87x | CN¥413.25 Million | CN¥124.78 Million | CN¥476.79 Million | ▼ -53.1% |
| 2020 | 1.85x | CN¥429.89 Million | CN¥93.62 Million | CN¥232.44 Million | ▲ +317.9% |
| 2019 | 0.44x | CN¥108.47 Million | CN¥-24.55 Million | CN¥245.10 Million | ▼ -35.2% |
| 2018 | 0.68x | CN¥163.52 Million | CN¥22.78 Million | CN¥239.44 Million | ▲ +3.5% |
| 2017 | 0.66x | CN¥135.56 Million | CN¥2.73 Million | CN¥205.47 Million | ▼ -0.3% |
| 2016 | 0.66x | CN¥125.58 Million | CN¥59.77 Million | CN¥189.73 Million | — |